Cyclerion Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCN and other ETFs, options, and stocks.

About CYCN

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate.

CEO

Regina Graul

CEORegina Graul

Employees

Employees1

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2018

Founded2018

Employees

Employees1

CYCN Key Statistics

Market cap

9.66M

Market cap9.66M

Price-Earnings ratio

-2.59

Price-Earnings ratio-2.59

Dividend yield

—

Dividend yield—

Average volume

19.09K

Average volume19.09K

High today

—

High today—

Low today

—

Low today—

Open price

$3.13

Open price$3.13

Volume

0.00

Volume0.00

52 Week high

$9.47

52 Week high$9.47

52 Week low

$1.27

52 Week low$1.27

People also own

Based on the portfolios of people who own CYCN. This list is generated using Robinhood data, and it’s not a recommendation.